Study guide
4.3 Dressing Categories, Formulary, and Resource Fit
Wound Care Certified WCC
Track your progress as you read
Finished sections get a check mark.
1 Orientation: NAWCO WCC Exam, Eligibility, and Scoring
1.1 Credential Purpose, Sponsor, and Scope 1.2 Qualifying License and Eligibility Frame 1.3 Education and Experience Pathways 1.4 Exam Format, Delivery, and Timing 1.5 Scoring, Standard Setting, and Confidentiality 1.6 Fees, Scheduling, Retesting, and Recertification
2 Wound Assessment: Etiology, Status, and Skin Integrity
2.1 Assessment Domain and Exam Approach 2.2 Etiology Patterns and Location Clues 2.3 Wound Status: Measurement, Tissue, and Exudate 2.4 Depth, Tissue Loss, and Pressure Injury Language 2.5 Skin Structure, Function, and Barrier 2.6 Skin Integrity Across the Lifespan
3 Patient Assessment: Labs, Nutrition, Pain, and Risk Tools
3.1 Labs and Diagnostic Data in Wound Assessment 3.2 Nutrition, Hydration, and Healing Risk 3.3 Comorbidities, Medications, and Current Condition 3.4 Psychosocial History, Adherence Barriers, and Access 3.5 Pain Assessment Tools and Treatment Tolerance 3.6 Risk Tools, Cognition, Function, and ADLs
4 Treatment Foundations, Dressings, and Wound Bed Preparation
4.1 Cleansing, Wound Hygiene, and Assessment Before Treatment 4.2 Moisture Balance and Core Dressing Functions 4.3 Dressing Categories, Formulary, and Resource Fit 4.4 Periwound Protection, Exudate, and Securement 4.5 Wound Bed Preparation and Debridement Concepts 4.6 Infection Signs, Prevention, and Escalation
5 Advanced Therapies, Diagnostics, Support Surfaces, and Referrals
5.1 Negative Pressure Wound Therapy Readiness and Monitoring 5.2 Electrical Stimulation, Ultrasound, and Topical Adjuncts 5.3 Diagnostics, Cultures, Labs, and Referral Triggers 5.4 Support Surfaces, Pressure Redistribution, and Microclimate 5.5 Offloading, Compression, and Lymphedema Decision-Making 5.6 Hyperbaric Oxygen and Specialty Referral Coordination
6 Infection, Vascular, Diabetic, and Pressure Injury Scenarios
6.1 Local, Spreading, and Systemic Infection Signals 6.2 Biofilm, Colonization, Culture, and Antimicrobial Traps 6.3 Diabetic Foot Ulcer Scenarios: Neuropathy, Perfusion, and Offloading 6.4 Venous, Arterial, and Mixed Vascular Wound Scenarios 6.5 Pressure Injury Prevention, Staging, and Treatment Scenarios 6.6 Integrated Contraindication and Priority Scenarios
7 Reevaluation, Healing Progression, and Treatment Adjustment
7.1 Re-Evaluation Domain and Decision Cycle 7.2 Treatment Choice and Plan Effectiveness 7.3 Weekly Measurement and Trend Monitoring 7.4 Tolerance, Pain, and Treatment Reactions 7.5 Adherence Barriers and Plan Adjustment 7.6 Healing Phases and Progression Decisions
8 Education, Health Literacy, and Interprofessional Teaching
8.1 Education Domain Scope and Priorities 8.2 Patient and Family Treatment-Plan Teaching 8.3 Health Literacy, Plain Language, and Teach-Back 8.4 Language, Cognition, Sensory Needs, and Cultural Adaptation 8.5 Discharge Teaching and Home Adherence 8.6 Interprofessional Team Teaching and Prevention Reinforcement
9 Administration, Protocols, Data Quality, and Care Coordination
9.1 Administration Domain Map for WCC Candidates 9.2 Evidence-Based Protocols and Facility Processes 9.3 Formularies, Product Access, and Treatment-Plan Workflow 9.4 Educational Media and Team Communication Tools 9.5 Data Quality, Prevalence, Incidence, and Outcome Monitoring 9.6 Payers, Case Management, and Transition Coordination
10 Legal Documentation, Ethics, Scope, and Patient Autonomy
10.1 Legal Domain Map for WCC Candidates 10.2 Objective Wound-Characteristic Documentation 10.3 Treatment-Plan Documentation and Continuity 10.4 Scope of Practice, Regulatory Issues, and Consultation 10.5 Ethics, Culture, Palliative Care, and Patient Autonomy 10.6 Confidentiality, Record Integrity, and Exam Conduct
11 Risk, Prevention, At-Risk Populations, and Product Selection
11.1 Risk Framework for Impaired Skin Integrity 11.2 Pressure Prevention, Repositioning, and Support Surfaces 11.3 Moisture, Incontinence, and Periwound Protection 11.4 Offloading, Foot Risk, and At-Risk Populations 11.5 Product Indications, Contraindications, and Selection 11.6 Population-Specific Prevention Across Settings
12 Integrated WCC Case Scenarios and Final Review
12.1 Blueprint-Weighted Final Review Strategy 12.2 Integrated Pressure Injury Case Review 12.3 Integrated Diabetic Foot and Vascular Case Review 12.4 Integrated Venous Leg Ulcer and Compression Case Review 12.5 Legal, Education, and Administration Integrated Cases 12.6 Exam Day, Scoring, Retake, and Recertification Review
4.3 Dressing Categories, Formulary, and Resource Fit
Key Takeaways Explain This Topic AI
Learn dressing categories by function: hydrogels donate moisture, foams/alginates/hydrofibers absorb, films protect low-drainage areas, contact layers reduce trauma, hydrocolloids support low-moderate moist healing.
Hydrocolloids and films are occlusive and contraindicated over infected wounds, heavy exudate, and dry ischemic eschar.
Alginates and hydrofibers need exudate to gel; placing them on a dry wound desiccates tissue and adheres.
Resource fit (formulary, payer limits, caregiver ability, care setting) is part of the Treatment blueprint; the sustainable appropriate product can beat the fancier one.
Last updated: June 2026
Categories Are Just Functions With Labels
The Treatment blueprint pairs "dressing and resource recommendations" with "product categories and functions." Resource is not filler: a dressing plan must work in the actual setting (acute, home health, long-term care, outpatient) where the patient receives care, and within payer and formulary limits.
Memorize categories by what they do, plus one key caution each.
- Category Primary Function Exudate Fit Key Caution / Contraindication
- Hydrogel (gel/sheet) Donates moisture, soothes Dry to minimal Macerates if used on moderate/heavy drainage
Transparent film Protects, retains moisture, allows visualization Minimal/none Not for infected or heavily draining wounds; can strip fragile skin
Hydrocolloid Occlusive moist healing, autolytic debridement Light to moderate Avoid over infection, heavy exudate, exposed bone/tendon
Foam Absorbs, cushions, insulates Moderate to heavy May need a filler for deep dead space
Alginate (calcium) High absorption, gels, mild hemostasis Moderate to heavy Dries out and adheres on low-exudate wounds
- Hydrofiber Very high absorption, vertical wicking Heavy Same dry-wound caution as alginate
- Contact layer Nonadherent interface, reduces trauma Any (needs cover) Not absorptive alone
Collagen Stimulates matrix, manages stalled wounds Low to moderate Not for dry eschar or active heavy infection
Antimicrobial (silver, iodine, PHMB, honey) Reduces bioburden Varies by base Requires an indication; reassess, do not use indefinitely
A few high-yield pairings the exam loves to invert: alginate on a dry wound (wrong, it desiccates), film over heavy exudate (wrong, it leaks and macerates), and hydrocolloid over a clinically infected wound (wrong, occlusion can worsen infection).
Know each category's special properties too. Hydrocolloids and films are occlusive and therefore support autolytic debridement, but that same occlusion is what makes them unsafe over infection. Calcium alginates have mild hemostatic action, which makes them useful after sharp debridement on a wound that oozes. Foams come in adhesive and nonadhesive forms, and bordered silicone foams reduce removal trauma on fragile skin. Collagen products supply a scaffold that can jump-start a stalled but viable wound, but they do nothing for dry eschar that has not yet been debrided.
Formulary, Payer, and the "Advanced Is Not Always Appropriate" Trap
Formulary questions test judgment, not memorization. When two products perform the same function, the available product that meets policy and cost limits is usually the better recommendation. When the on-formulary product cannot meet the wound's need, the WCC role is to communicate the clinical rationale for an alternate through the proper process, not to improvise outside orders.
Antimicrobial dressings are common distractors. Silver, cadexomer iodine, polyhexamethylene biguanide (PHMB), and medical-grade honey are appropriate when local bioburden or infection is a concern and policy supports use. They are not automatically required for every chronic wound, and silver in particular should be reassessed (commonly around a 2-week checkpoint) rather than continued reflexively. Many silver products are also not recommended during MRI or radiation therapy, a detail that occasionally appears.
Applied Scenario
A home-health patient has a moderately draining, shallow wound, fragile periwound skin, limited caregiver help, and a payer cap on supply quantity. The best answer is not the most complex product. It is the plan that matches the exudate (an absorptive foam), protects the skin (a barrier film), can be changed safely and infrequently by the available caregiver, is obtainable under the payer limit, and follows the provider's order.
Step 1: Name the function (moisture, absorption, fill, protection, atraumatic, antimicrobial).
Step 2: Confirm the patient, setting, formulary, and policy allow consistent use.
Trap: occlusive products over untreated infection, heavy exudate, or dry ischemic eschar.
Trap: ignoring removal injury. A dressing that controls drainage but strips skin or bleeds at each change is the wrong fit; weigh securement, adhesive sensitivity, location, and change-related pain.
This two-step approach (function, then feasibility) resolves the large majority of dressing-category items on the WCC exam.
Negative Pressure and Advanced Therapies
When a stem describes a large, deep, heavily draining wound with dead space, negative pressure wound therapy (NPWT) may appear as an option. NPWT applies controlled subatmospheric pressure to remove exudate, reduce edema, promote granulation, and approximate edges. It is contraindicated over untreated osteomyelitis, malignancy in the wound, exposed vessels or organs, and necrotic tissue with eschar that has not been debrided, and it requires intact periwound skin for the seal. The WCC role is to recognize candidacy and contraindications and to coordinate the ordered plan, not to initiate advanced therapy independently.
Similarly, products like medical-grade honey and cadexomer iodine carry both an antimicrobial and an autolytic-debriding action, which can make them attractive on a sloughy, malodorous wound, but honey is osmotic and will increase exudate volume initially, so the dressing plan must account for that extra drainage. The recurring theme across the formulary is the same: every advanced product earns its place only by matching the wound's current need, the care setting, and the patient's ability to use it safely and consistently.